The so-called stunning of thyroid tissue

Journal of Nuclear Medicine

Volumn 47, Issue 9, 2006, Pages 1406-1412

  Sisson, James C ^a   Avram, Anca M ^a   Lawson, Susan A ^a   Gauger, Paul G ^a   Doherty, Gerard M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Radioiodine therapy; Stunning; Thyroid carcinoma

Indexed keywords

IODINE 131; THYROTROPIN; THYROXINE; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CERVICAL LYMPH NODE; DIET; DOSE RESPONSE; DRUG TISSUE LEVEL; DRUG UPTAKE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RADIOACTIVITY; THYROID CARCINOMA; ADOLESCENT; AGED; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; INJURY; METHODOLOGY; MIDDLE AGED; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; RISK ASSESSMENT; RISK FACTOR; SCINTISCANNING; THYROID DISEASE; THYROID GLAND; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIATION INJURIES; RADIATION PROTECTION; RISK ASSESSMENT; RISK FACTORS; THYROID DISEASES; THYROID GLAND; THYROID NEOPLASMS;

EID: 33750604002     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Park H-M, Perkins OW, Edmonson JW, Schnute RB, Manatunga A. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131. Thyroid. 1994;4:49-54.
2. 131I scintigraphy. Nucl Med Commun. 2000;21:529-532.
3. 131I whole-body scan? Clin Endocrinol (Oxf). 2004;61:704-710.
4. Lakshmanan M, Schaffer A, Robbins J, Norton J. A simplified low iodine diet in I-131 scanning and therapy of thyroid cancer. Clin Nucl Med. 1988;13:866-868.
5. Welch JC, Potchen EJ, Welch MJ. Fundamentals of the Tracer Method. Philadelphia, PA: W.B. Saunders Co.; 1972:171-172.
6. 131I. J Nucl Med. 2003;44:898-903.
7. Hermanek P, Sobin LH. UICC: TNM Classification of Malignant Tumours. 4th ed. New York, NY: Springer-Verlag; 1987:32-35.
8. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome of papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114:1050-1058.
9. Kao C-H, Yen T-C. Stunning effects after a diagnostic dose of iodine-131. Nuklearmedizin. 1998;37:23-25.
10. 131I (i.e. it does not cause stunning) in differentiated thyroid cancer. Nucl Med Commun. 1997;18:505-512.
11. 131I therapeutic efficacy is not influenced by stunning after diagnostic whole-body scanning. Radiology. 2004;232:527-533.
12. 131I on postsurgical thyroid remnants. J Nucl Med. 2000;41:2038-2042.
13. Muratet J-P, Daver A, Minier J-F, Larra F. Influence of scanning doses of iodine-131 on subsequent first ablative treatment outcome in patients operated on for differentiated thyroid carcinoma. J Nucl Med. 1998;39:1546-1550.
14. 131I-scanned and nonscanned individuals. J Clin Endocrinol Metab. 2001;86:3507-3511.
15. 131I. J Nucl Med. 2000;41:1198-1202.
16. Yeung HWD, Humm JL, Larson SM. Radioiodine uptake in thyroid remnants during therapy after tracer dosimetry. J Nucl Med. 2000;41:1082-1085.
17. 131I. Nucl Med Commun. 1996;17:839-842.
18. 131I diagnostic activities on the biokinetics of thyroid remnants. J Nucl Med. 2004;45:619-625.
19. Leger FA, Izembart M, Dagousset F, et al. Decreased uptake of therapeutic doses of iodine-131 after 185-MBq iodine-131 diagnostic imaging for thyroid remnants in differentiated thyroid carcinoma. Eur J Nucl Med. 1998;25:242-246.
20. Jeevanram RK, Shah DH, Sharma M, Ganatra RD. Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients. Nucl Med Biol. 1986;1:277-279.
21. Sabri O, Zimny M, Schreckenberger M, Meyer-Oelmann A, Reinartz P, Buell U. Does thyroid stunning exist? A model with benign thyroid disease. Eur J Nucl Med. 2000;27:1591-1597.
22. 131I irradiation in cultured thyroid epithelial cells. J Nucl Med. 2002;43:828-834.
23. 131iodine activity - results from a prospective, randomized, multicentre study. Eur J Clin Invest. 1995;25:186-193.
24. Leslie WD, Ward L, Salamon EA, Ludwig S, Rowe RC, Cowden EA. A randomized comparison of radioiodine doses in Graves' hyperthyroidism. J Clin Endocrinol Metab. 2003;88:978-983.
25. 131I activities and radioiodine therapy: effects on urinary iodine excretion in patients with differentiated thyroid carcinoma. Nuklearmedizin. 2005;44:243-248.